Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally. It develops nutritional supplements, food ingredients, meat replacements, and by-products using safflowers, chickpeas, fungi, soybeans, and yeast, as well as lupin and peas. The company is based in Grand Cayman, Cayman Islands.
Moolec Science SA Regains Compliance with All Nasdaq Capital Market Continued Listing Requirements Within Panel Remediation Period
Moolec Science has regained compliance with all Nasdaq Capital Market continued listing requirements within the remediation period granted by the Nasdaq Hearings Panel.
The company reported stockholders' equity of approximately $11.3 million as of March 31, 2026, down from $15.2 million as of December 31, 2025.
Moolec expects to notify the holder to convert the remaining $4.0 million of the original aggregate preference share amount within the next 12 months, which is expected to further strengthen stockholders' equity.